#126 Fecal Microbial Transplants (FMT) Immunology and Clinical Updates

This is a product page for purchasing this course. To register for this course click here

1.5 CME Total | 1.5 Pharm

Fecal Microbiota Transplantation (FMT) was first described in the Chinese literature when Li Shizhen treated gastrointestinal diseases with “fresh yellow soup” which contained raw fecal material. ‘During the World War II, German soldiers were treated in Africa with FMT for dysentery. In medical literature, Ben Eiseman, a surgeon from Colorado-USA, treated patients with pseudomembranous colitis using fecal enemas.’ Fecal Microbiota transplantation has gained popularity during the epidemic appearance of Clostridium difficile infection resistant to usual treatments. The FDA regulated human feces in 2013 as an approved drug for treating Clostridium difficile infection. In the years since 2013 FMT has been proposed for use outside C. difficile infection in other areas of immunology. The purpose of this CME is to give an overview of FMT for clinicians to be prepared to refer for FMT procedures in appropriate patients. [Quotes from PMID: 27453747]